A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic (PK-the study of the way a drug
enters and leaves the blood and tissues over time) characteristics of bortezomib when
administered intravenously in Taiwanese participants with multiple myeloma (cancer of the
types of cells normally found in bone marrow).